50% off Premium Yearly
Ishares Nasdaq BiotechnologyIBBPAST TOP PICKOct 15, 2018Stock price when the opinion was issued
As of Jun 18, 2026. Market Open.
Healthcare sector outlook The sector has had a great bounce since March lows. A good way to play the COVID vaccine race. IBB is the best-known biotech ETF, but he does the XBI, because it's equal-weighted. XBI has had a great bounce. It's a great sector with reasonable valuations. The race for a COVID vaccine is a tailwind, of course. Biotech is a slow-growth area, which benefit from interest rates staying very low for the long term.
(A Top Pick Nov. 17/17, Up 7%) There was a three for one stock split. This and healthcare are in a long term secular bull market. You have to live with the volatility and this is why he likes the ETF. He would hold it long term.